BRITTANY POLIZZI: Open Payments
NPI 1821692336 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,135 in 136 payments from 17 companies in 2025. Trend: 2023 $3,871 · 2024 $14,177 · 2025 $14,135
Speaker / faculty: $8,250Food & beverage: $2,215Consulting: $2,150Travel & lodging: $1,511Education: $10
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 33 | $11,998 |
| UCB, Inc. | 12 | $334 |
| ABBVIE INC. | 21 | $324 |
| GENZYME CORPORATION | 12 | $249 |
| Janssen Biotech, Inc. | 16 | $211 |
| Organon LLC | 7 | $193 |
| Galderma Laboratories, L.P. | 8 | $162 |
| Incyte Corporation | 5 | $134 |
| LEO Pharma Inc. | 4 | $115 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $97 |
Products named: EBGLYSS, Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, VTAMA, OPZELURA, RINVOQ.
Industry payments across CA — which companies pay providers there.
